doc. MUDr. Tomáš Koller, PhD.
Vedecko/umelecko-pedagogická charakteristika:
Najvýznamnejšie výstupy tvorivej činnosti:
1. | Koller T, Kollerova J, Hlavaty T, Huorka M, Payer J. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. Scand J Gastroenterol. 2012 | Q | IF |
2. | Skladany L, Koller T, Molcan P, Vnencakova J, Zilincan M, Jancekova D, Kukla M. Prognostic usefulness of serum myostatin in advanced chronic liver disease: its relation to gender and correlation with inflammatory status. J Physiol Pharmacol. 2019 | Q | IF |
3. | Koller T, Galambosova M, Filakovska S, Kubincova M, Hlavaty T, Toth J, Krajcovicova A, Payer J. Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study. World J Gastroenterol. 2017 | Q | IF |
4. | Koller T, Kollerova J, Huorka M, Meciarova I, Payer J. Noninvasive scoring algorithm to identify significant liver fibrosis among treatment-naive chronic hepatitis C patients. Eur J Gastroenterol Hepatol. 2014 | Q | IF |
5. | Skladany L, Vnencakova J, Laffers L, Skvarkova B, Hrubá E, Molcan P, Koller T. Adherence to Oral Nutritional Supplements After Being Discharged from the Hospital is Low but Improves Outcome in Patients with Advanced Chronic Liver Disease. Patient Prefer Adherence. 2021 | Q | IF |